FORA Capital, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1742435 MIAMI, FL

Position in ALNY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,568,065

+$88,746 QoQ

Shares Held

5,209

+16.5% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#353

of 784 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FORA Capital, LLC holds $19,737,715 across 20 Biotechnology names. ALNY ranks #1 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc. This page	5,209	$1,568,065
2	ABVX	Abivax S.A.	11,758	$1,566,871
3	ROIV	Roivant Sciences Ltd.	44,129	$1,561,725
4	AXSM	Axsome Therapeutics, Inc.	6,364	$1,557,716
5	TVTX	Travere Therapeutics, Inc.	27,289	$1,550,288
6	PRAX	Praxis Precision Medicines, Inc.	4,205	$1,407,791
7	REGN	Regeneron Pharmaceuticals, Inc.	2,147	$1,338,740
8	JAZZ	Jazz Pharmaceuticals plc	5,408	$1,303,165

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,568,065	5,209	+16.5%	Shares	Sole	2026-08-13
2026-03-31	$1,479,319	4,471	+29.0%	Shares	Sole	2026-05-15
2025-12-31	$1,378,254	3,466	+27.5%	Shares	Sole	2026-02-13
2025-09-30	$1,239,864	2,719	-68.5%	Shares	Sole	2025-11-13
2025-03-31	$2,328,652	8,624	-32.1%	Shares	Sole	2025-05-14
2024-12-31	$2,987,966	12,698	+77.0%	Shares	Sole	2025-02-14
2024-06-30	$1,743,039	7,173	+320.7%	Shares	Sole	2024-08-13
2023-12-31	$326,354	1,705	-80.6%	Shares	Sole	2024-02-14
2022-09-30	$1,756,203	8,774	+293.6%	Shares	Sole	2022-11-14
2021-09-30	$420,857	2,229	-16.3%	Shares	Sole	2021-11-15
2021-06-30	$451,601	2,664	-62.1%	Shares	Sole	2021-08-16
2020-06-30	$1,040,620	7,026	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.